T1411I (p.Thr1411Ile) variant of EP300 (Histone acetyltransferase p300)
T1411I (p.Thr1411Ile) in EP300 (Histone acetyltransferase p300) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Rubinstein-Taybi syndrome due to EP300 haploinsufficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes published literature and structural context.
T1411I (p.Thr1411Ile) variant details
- p.Thr1411Ile
- rs1601633708
- ClinGen CA411701721
- ClinVar RCV000825020
- Ensembl rs1601633708
- Likely pathogenic
- Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
- Missense
- Variant Prioritization Score for Impact Estimate 0.838
- MutPred 0.84
- ClinVar: Likely pathogenic (Rubinstein-Taybi syndrome due to EP300 haploinsufficiency)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Structural context available
- Cited in: Rubinstein-Taybi Syndrome. (PMID 20301699)